INDEPENDENT TRANSCRIPTIONAL ACTIVATION; HEPATIC CB1 RECEPTOR; FATTY LIVER-DISEASE; ENDOCANNABINOID SYSTEM; RISK-FACTOR; PLASMA-FIBRINOGEN; LEPTIN RESISTANCE; INVERSE AGONIST; GAMMA; OBESITY
PLOS ONE, v.12, no.7
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.